N/A
Completed N=86
Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead
Source: ClinicalTrials.gov NCT00763698 ↗Enrolled (actual)
86
Serious AEs
4.7%
Results posted
Nov 2011
Primary outcomePrimary: Freedom From Left Ventricular Lead-related Complications — 100 percent of participants
Summary
This is a prospective, multi-center non-randomized clinical study to evaluate the safety and efficacy of the QuickFlex Micro Model 1258T left ventricular lead in a heart failure patient population. The study will be conducted at a maximum of 20 investigational centers located in the United States and a total of 68 patients will be enrolled.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Freedom From Left Ventricular Lead-related Complications |
100 | — |
| PRIMARY Percentage of Successful Left Ventricular Lead Implants |
94 | — |
| PRIMARY Left Ventricular Bipolar Pacing Capture Threshold (Volts) |
1.1 | — |
Eligibility Criteria
Inclusion Criteria
- Approved indication for CRT-D system
Exclusion Criteria
- Previous cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 3 months of enrollment
- Previous left ventricular (LV) lead implant
- Have had a heart attack, unstable angina or cardiac revascularization (percutaneous transluminal coronary angioplasty (PTCA),coronary artery bypass grafting (CABG), Stent) within 40 days prior to enrollment
Data sourced from ClinicalTrials.gov (NCT00763698). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.